Mark Haden, Psychedelic Medicine Expert, Joins Clearmind Medicine’s Advisory Board
03 août 2021 07h00 HE
|
Clearmind Medicine
Toronto, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery and development of...